Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Top-read JCI Insight articles of 2016

January 21st is the first anniversary of JCI Insight's debut issue. Below, we've highlighted the top-read articles from its first year of publication:


10. Vascular mineralocorticoid receptor regulates microRNA-155 to promote vasoconstriction and rising blood pressure with aging. Jennifer J. DuPont,
 Amy McCurley, Ana P. Davel, Joseph McCarthy, Shawn B. Bender, Kwangseok Hong, Yan Yang, Jeung-Ki Yoo, Mark Aronovitz, Wendy E. Baur, Demetra D. Christou, Michael A. Hill, and Iris Z. Jaffe.

9. Soluble ADAM33 initiates airway remodeling to promote susceptibility for allergic asthma in early life. Elizabeth R. Davies, Joanne F.C. Kelly, Peter H. Howarth,
David I. Wilson, Stephen T. Holgate, Donna E. Davies, Jeffrey A. Whitsett, and Hans Michael Haitchi.

8. Heterogeneous fibroblasts underlie age-dependent tertiary lymphoid tissues in the kidney. Yuki Sato, Akiko Mii, Yoko Hamazaki, Harumi Fujita,  Hirosuke Nakata,
 Kyoko Masuda, Shingo Nishiyama, Shinsuke Shibuya, Hironori Haga, Osamu Ogawa, Akira Shimizu, Shuh Narumiya, Tsuneyasu Kaisho, Makoto Arita, Masashi Yanagisawa,
 Masayuki Miyasaka, Kumar Sharma, Nagahiro Minato, Hiroshi Kawamoto, and Motoko Yanagita.

7. Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata. Julian Mackay-Wiggan, Ali Jabbari, Nhan Nguyen, 
Jane E. Cerise, Charlotte Clark, Grace Ulerio, Megan Furniss, Roger Vaughan, Angela M. Christiano, and Raphael Clynes. 

6. PD-1 blockade enhances the vaccination-induced immune response in glioma. Joseph P. Antonios, Horacio Soto, Richard G. Everson, Joey Orpilla, 
Diana Moughon, Namjo Shin, Shaina Sedighim, William H. Yong, Gang Li, Timothy F. Cloughesy, Linda M. Liau, and Robert M. Prins. 

5. The MEK inhibitor trametinib separates murine graft-versus-host disease from graft-versus-tumor effects. Hidekazu Itamura, Takero Shindo, Isao Tawara, 
Yasushi Kubota, Ryusho Kariya, Seiji Okada, Krishna V. Komanduri, and Shinya Kimura.

4. Elimination of p19ARF-expressing cells enhances pulmonary function in mice. Michihiro Hashimoto, Azusa Asai, Hiroyuki Kawagishi, Ryuta Mikawa,
 Yuji Iwashita, Kazuki Kanayama, Kazushi Sugimoto, Tadashi Sato, Mitsuo Maruyama, and Masataka Sugimoto. 

3. Zika virus productively infects primary human placenta-specific macrophages. Kellie Ann Jurado, Michael K. Simoni, Zhonghua Tang, Ryuta Uraki, Jesse Hwang,
 Sarah Householder, Mingjie Wu, Brett D. Lindenbach, Vikki M. Abrahams, Seth Guller, and Erol Fikrig. 

2. Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata. Milène Kennedy Crispin, Justin M. Ko, Brittany G. Craiglow,
 Shufeng Li, Gautam Shankar, Jennifer R. Urban, James C. Chen, Jane E. Cerise, Ali Jabbari, Mårten C.G. Winge, M. Peter Marinkovich, Angela M. Christiano, Anthony E. Oro,
 and Brett A. King.

1. A wearable artificial kidney for patients with end-stage renal disease. Victor Gura, Matthew B. Rivara, Scott Bieber, Raj Munshi, Nancy Colobong Smith,
 Lori Linke, John Kundzins, Masoud Beizai, Carlos Ezon, Larry Kessler, and Jonathan Himmelfarb.

Published January 1, 2017, by Elyse Dankoski

In the News

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts